Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dogwood Therapeutics, Inc. - Common Stock (NQ:DWTX)

2.530 -0.100 (-3.80%)
Streaming Delayed Price Updated: 1:30 PM EDT, Sep 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 41,506
Open 2.600
Bid (Size) 2.500 (1,000)
Ask (Size) 2.560 (200)
Prev. Close 2.630
Today's Range 2.450 - 2.660
52wk Range 1.280 - 9.500
Shares Outstanding 1,332,178
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dogwood Therapeutics Nears Phase 2b Readout for Halneuron Neuropathic Pain Treatment ↗
Dogwood Therapeutics (NASDAQ:DWTX) said its Phase 2b study of Halneuron, an investigational treatment for chemotherapy-induced neuropathic pain, has enrolled more than 230 patients and is expected to... 
Via MarketBeat
Dogwood Therapeutics (NASDAQ:DWTX) Beats EPS Estimates in Q1 2026, Phase 2b Trial on Track ↗
Via Chartmill

Performance

YTD
-40.3%
-40.3%
1 Month
+48.0%
+48.0%
3 Month
+51.5%
+51.5%
6 Month
-13.7%
-13.7%
1 Year
-47.4%
-47.4%

More News

Read More
News headline image
DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence ↗
Via Stocktwits
News headline image
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045
Via ACCESS Newswire
News headline image
Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics Inc (NASDAQ:DWTX) Reports Q3 2025 Results, Focuses on Key Halneuron® Data ↗
Via Chartmill
Topics Earnings
News headline image
Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics to Participate at the Maxim Growth Summit 2025
Via ACCESS Newswire
News headline image
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
Via ACCESS Newswire
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Here are the top movers in Monday's session. ↗
Via Chartmill
News headline image
Which stocks have an unusual volume on Monday? ↗
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
Nasdaq Tumbles Over 400 Points; Netflix Posts Upbeat Earnings ↗
Via Benzinga
News headline image
Which stocks are moving on Thursday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is Dogwood Therapeutics, Inc. - Common Stock publicly traded?
Yes, Dogwood Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Dogwood Therapeutics, Inc. - Common Stock trade on?
Dogwood Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Dogwood Therapeutics, Inc. - Common Stock?
The ticker symbol for Dogwood Therapeutics, Inc. - Common Stock is DWTX on the Nasdaq Stock Market
What is the current price of Dogwood Therapeutics, Inc. - Common Stock?
The current price of Dogwood Therapeutics, Inc. - Common Stock is 2.530
When was Dogwood Therapeutics, Inc. - Common Stock last traded?
The last trade of Dogwood Therapeutics, Inc. - Common Stock was at 09/02/26 01:30 PM ET
What is the market capitalization of Dogwood Therapeutics, Inc. - Common Stock?
The market capitalization of Dogwood Therapeutics, Inc. - Common Stock is 3.37M
How many shares of Dogwood Therapeutics, Inc. - Common Stock are outstanding?
Dogwood Therapeutics, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.